ROCKVILLE, MD
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)AMERICAN SOCIETY FOR PHARMACOLOGY & EXPERIMENTAL THERAPEUTICS, founded in 1933, is a community nonprofit in the Health Care sector that reported $5.7M in total revenue in fiscal year 2023. Revenue surged 28% from the prior year, signaling strong growth momentum. Expenses of $7.1M exceeded revenue, resulting in a 25% operating deficit.
THE AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (ASPET) IS A 4,000 MEMBER SCIENTIFIC SOCIETY WHOSE MEMBERS CONDUCT BASIC AND CLINICAL PHARMACOLOGICAL RESEARCH AND WORK FOR ACADEMIA, GOVERNMENT, LARGE PHARMACEUTICAL COMPANIES, SMALL BIOTECH COMPANIES, AND NON-PROFIT ORGANIZATIONS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $5,712,373 | $4,463,274 | +0.3% |
| Expenses | $7,144,205 | $5,114,519 | +0.4% |
| Net Income | $-1,431,832 | $-651,245 | +1.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| XINXIN DING | SEC/TREAS ELECT, THEN SEC/TREAS | 5.00 |
Officer
Director
|
$35,000 | $0 | $35,000 |
| MICHAEL L JARVIS | PRESIDENT, THEN PAST PRESIDENT | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| NAMANDJE BUMPUS | PRESIDENT ELECT, THEN PRESIDENT | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| MARGARET GNEGY | PAST PREDIDENT | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| KATHRYN CUNNINGHAM | SEC/TREAS, THEN PAST SEC/TREAS | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| CAROL BECK | PAST SEC/TREAS, THEN PRES ELECT | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| PAM HORNBY | SEC/TREAS ELECT | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| RANDY HALL | COUNCILOR | 5.00 |
Director
|
$0 | $0 | $0 |
| JOHN TRAYNOR | COUNCILOR | 5.00 |
Director
|
$0 | $0 | $0 |
| NINA ISOHERRANEN | COUNCILOR | 5.00 |
Director
|
$0 | $0 | $0 |
| DAVID JACKSON | EXECUTIVE OFFICER | 40.00 |
Officer
|
$305,502 | $10,959 | $316,461 |
| ROBERT STANLEY | CHIEF FINANCIAL OFFICER | 40.00 |
Officer
|
$203,566 | $40,419 | $243,985 |
| MELISSA HUSTON | MEETINGS DIRECTOR | 40.00 |
Highest
|
$150,741 | $28,675 | $179,416 |
| MARIA PASHO | JOURNAL DIRECTOR | 40.00 |
Highest
|
$161,777 | $22,365 | $184,142 |
| LYNNE HARRIS | MARKETING DIRECTOR | 40.00 |
Highest
|
$152,835 | $15,170 | $168,005 |
| CATHERINE FRY | EDUCATION DIRECTOR | 40.00 |
Highest
|
$152,636 | $33,727 | $186,363 |
| CARTER ALLEMAN | GOVT AFFAIRS & SCIENCE POL DIRECTOR | 40.00 |
Highest
|
$146,577 | $5,103 | $151,680 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $5,712,373 | $7,144,205 | $30,249,773 | $-1,431,832 |
| 2022 | $4,463,274 | $5,114,519 | $29,344,018 | $-651,245 |
| 2021 | $7,613,751 | $4,699,167 | $33,893,150 | $2,914,584 |
| 2020 | $4,904,674 | $4,608,155 | $30,160,576 | $296,519 |
| 2019 | $5,562,695 | $5,083,355 | $27,322,547 | $479,340 |
| 2018 | $5,505,934 | $5,134,580 | $22,578,825 | $371,354 |
Compare AMERICAN SOCIETY FOR PHARMACOLOGY & EXPERIMENTAL THERAPEUTICS with other nonprofits in Maryland and across the country.